Pune, Feb. 14, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Automated Breast Ultrasound Systems Market is expected to clock US$ 10.11 billion by 2031 and to grow at a CAGR of 14.2% during the forecast period.
The global Automated Breast Ultrasound Systems (ABUS) Market is experiencing significant growth, driven by advancements in breast cancer screening technology, rising awareness of breast health, and the need for more accurate and accessible diagnostic tools. A comprehensive analysis of the market reveals a dynamic landscape dedicated to improving early detection and outcomes for women at risk of breast cancer.
Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/automated-breast-ultrasound-systems-market/8482
Automated Breast Ultrasound Systems Market Scope
| Report Attribute | Details |
| Market Size Value in 2022 | US$ 3.06 billion |
| Revenue Forecast in 2031 | US$ 10.11 billion |
| CAGR | 14.2% |
| Base Year for Estimation | 2022 |
| Forecast Period | 2023-2031 |
| Historical Year | 2021 |
| Segments Covered | Product, End User, and Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Market Overview:
Automated Breast Ultrasound Systems (ABUS) are innovative medical devices designed to enhance breast cancer screening for women with dense breast tissue. Unlike traditional mammography, which may be less effective in detecting tumors in dense breasts, ABUS utilizes ultrasound technology to provide detailed images of breast tissue, aiding in the early detection of breast cancer in asymptomatic women and those with dense breasts.
Key Market Drivers:
- Growing Awareness of Breast Density: Dense breast tissue is a significant risk factor for breast cancer and can make it challenging to detect tumors on mammograms. As awareness of breast density increases among healthcare providers and patients, there is a growing demand for supplemental screening modalities, such as ABUS, to improve the sensitivity and accuracy of breast cancer detection in women with dense breasts.
- Advancements in Ultrasound Technology: Rapid advancements in ultrasound technology, including improvements in image resolution, 3D imaging capabilities, and automated scanning features, drive innovation in ABUS systems. These technological enhancements enable healthcare providers to obtain high-quality breast images quickly and efficiently, facilitating early detection of breast cancer and reducing false-positive results.
- Focus on Personalized Medicine: The shift towards personalized medicine and patient-centric care drives the adoption of ABUS as a complementary screening tool for women with specific risk factors, such as dense breast tissue or a family history of breast cancer. ABUS offers a non-invasive and radiation-free alternative to other imaging modalities, making it well-suited for regular breast cancer screening in high-risk populations.
Competitive Landscape:
The Automated Breast Ultrasound Systems (ABUS) market features a competitive landscape with key players focusing on product innovation, strategic partnerships, and geographical expansion to gain a competitive edge. Companies invest in research and development to launch next-generation ABUS systems with improved imaging capabilities and user-friendly interfaces.
Challenges and Opportunities:
While the ABUS market presents significant opportunities for improving breast cancer screening and detection, challenges such as reimbursement limitations, operator training requirements, and patient acceptance need to be addressed. However, ongoing advancements in technology, increasing adoption of artificial intelligence for image analysis, and collaborative efforts between industry stakeholders offer avenues for market growth and expansion.
Table of Content
- INTRODUCTION
-
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2021
- Base Year – 2022
- Forecast Years – 2023 to 2031
- Currency Used in the Report
- RESEARCH METHODOLOGY
-
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
-
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2022)
- Regulatory Landscape
- MARKET DYNAMICS
-
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET - ANALYSIS & FORECAST, BY PRODUCT
-
- Automated Breast Ultrasound System
- Automated Breast Volume Scanner
- GLOBAL AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET - ANALYSIS & FORECAST, BY END USER
-
- Hospitals
- Diagnostics Imaging Laboratories
- Others
Future Outlook:
The Automated Breast Ultrasound Systems (ABUS) market is poised for continued growth, driven by the growing demand for supplemental breast cancer screening modalities, advancements in ultrasound technology, and the emphasis on early detection and personalized medicine. As ABUS becomes more widely adopted as part of comprehensive breast health programs, it has the potential to improve breast cancer detection rates and reduce unnecessary interventions, ultimately saving lives.
In conclusion, the Automated Breast Ultrasound Systems (ABUS) Market represents a significant advancement in breast cancer screening technology, offering a non-invasive, radiation-free solution for women with dense breast tissue. By leveraging cutting-edge ultrasound technology and fostering collaboration across the healthcare ecosystem, stakeholders can work together to improve breast health outcomes and empower women to take control of their health.
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8482
Browse other reports:
The global Salmonella treatment market is expected to register a revenue CAGR of 7.3% during the forecast period from 2022 to 2030.
According to the deep-dive market assessment study by Growth Plus Reports, the global scoliosis management market was valued at US$ 2.2 billion in 2021 and is expected to register a revenue CAGR of 4.3% to reach US$ 3.21 billion by 2030.
According to the deep-dive market assessment study by Growth Plus Reports, the global sterilization indicator tape market was valued at US$ 121 million in 2021 and is expected to register a revenue CAGR of 3.8% to reach US$ 169.26 million by 2030.
According to the deep-dive market assessment study by Growth Plus Reports, the global surgical drill market was valued at US$ 1.2 billion in 2021 and is expected to register a revenue CAGR of 6.1% to reach US$ 2.04 billion by 2030.
Based on the deep-dive market assessment study by Growth Plus Reports, the global Whole exome sequencing market was valued at US$ 1.02 billion in 2021 and is expected to register a revenue CAGR of 18.70% to reach US$ 4.80 billion by 2030.
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
